Corneile Liebenberg

Chief Digital Officer (cdo) at nuvoteQ.io

Corneile Liebenberg is a seasoned professional in the digital and media industry, currently serving as the Chief Digital Officer at nuvoteQ.io since February 2023. Previously, Corneile held significant roles at KRAFT designsmiths® as both Managing Director and Non Executive Director. As a co-owner and Managing Director at Karbonblack from February 2009 to November 2019, Corneile also founded The Dot Digital Media, which later merged with Karbonblack. Early career experiences include positions at Oscar Tango and Plofstof Media (Pty) Ltd as Account Manager and Co-Founder/Managing Director, respectively, along with a role as Junior Oracle Consultant at Global BITS. Educational background includes a BIS in Multimedia from the University of Pretoria and a course at the Ogilvy Digital Marketing Academy.

Location

Johannesburg, South Africa

Links


Org chart


Teams

This person is not in any teams


Offices


nuvoteQ.io

BUILT LOCALLY... TRUSTED GLOBALLY... In the fast-paced world of clinical research, getting medicines to market quickly and effectively is paramount. Clinical research organisations (CROs) face the challenge of conducting clinical trials in an affordable and efficient manner. However, existing methods and tools often fall short, being inflexible, slow, expensive, and lacking accuracy. Furthermore, there is a significant gap in credible and capable local solutions to support clinical trials. CROs who fail to perform effective clinical trials run the risk of not launching their products on time, losing significant market share and in some cases, even forfeiting the patent of their products. nuvoteQ is a trusted provider of digital technology solutions in the clinical and pharmaceutical research space. Based in Africa, we have developed a range of software products that are trusted by leading organisations worldwide. Our mission is to deliver cost-effective, flexible, and accessible software solutions with precise and high-quality results. nuvoteQ offers a range of powerful software products designed to empower clinical and pharmaceutical research organisations. With a proven track record and successful collaborations with industry giants, nuvoteQ has gained the trust of our clients. They rely on us to deliver exceptional service and results, allowing us to foster long-term partnerships. Additionally, we have established public partnerships, including our affiliation with the Gates Foundation. Our global footprint spans five continents and over 40 countries, reflecting the breadth of our reach. It's worth noting that all our work and platforms are FDA-approved, ensuring regulatory compliance and quality assurance.


Employees

11-50

Links